发布时间: 2025 - 07 - 31
In July, Cloudbreak Therapeutics, a portfolio company of Efung Capital, successfully landed on the Hong Kong Stock Exchange. Oryzogen and Biotyx Medical became the first two companies to pass the IPO review under the Fifth Set of Standards on the STAR Market, while TnMab became the first company to have its IPO application accepted under the same standard since its restart.While continuing to gain momentum in the biopharmaceutical sector, other Efung Capital portfolio companies also delivered outstanding performance.01 Portfolio Company Listing and Financing ProgressCloudbreak TherapeuticsFirs...
浏览次数:2
发布时间: 2025 - 07 - 30
The New Quality Productive Forces Seminar, co-hosted by the Macroeconomic Magazine of the National Development and Reform Commission and the Editorial Committee of the China Private Equity Fund Yearbook, was successfully held. During the seminar, the China Private Equity Fund Yearbook (2024) was officially released.To provide a more comprehensive overview of the industry's development, the Editorial Committee of the China Private Equity Fund Yearbook conducted a comprehensive evaluation of over 20,000 private equity fund managers in China across more than 20 dimensions, leveraging its data...
浏览次数:1
发布时间: 2025 - 07 - 30
On July 30, 2025, Hao Yue Capital officially released the "9th Healthcare Investment Excellence Awards." Efung Capital was recognized as "Best Early-Stage Healthcare Investment Institution of the Year" and "Best Innovative Pharmaceutical Investment Institution of the Year." Mr. Zhu Pui, CEO of Efung Capital, was honored as "Young Healthcare Investor of the Year."Now in its ninth year, the "Healthcare Investment Excellence Awards," meticulously established by Hao Yue Capital, continue to be grounded in the principles of "fairness, justice, ...
浏览次数:2
发布时间: 2025 - 07 - 29
On July 28, 2025, amidst the rising chorus of summer cicadas, we welcome a day filled with care – the 15th "World Hepatitis Day."This year, China's theme is "Social Co-governance to Eliminate Hepatitis," like a gentle ray of sunshine, calling on us to slow down and pay collective attention to lives silently enduring the pain of illness. Let us join hands to convey understanding and hope, infusing warm strength into the effort to eliminate the harm caused by hepatitis.01 Current Status and Challenges of Viral HepatitisIn China, the prevention and control of viral hepatit...
浏览次数:4
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务